Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system - PubMed (original) (raw)

Review

Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system

M Oprica et al. J Cell Mol Med. 2003 Apr-Jun.

Abstract

The evidence of inflammatory processes in the clinical manifestations and neuropathological sequelae of epilepsy have accumulated in the last decade. Administration of kainic acid, an analogue of the excitatory amino acid glutamate, induces a characteristic behavioural syndrome and a reproducible pattern of neurodegeneration in several brain areas, closely resembling human temporal lobe epilepsy. Results from studies using the kainic acid model indicate that manipulation of pro- and anti-inflammatory cytokines can modify the outcome with regard to the behavioural syndrome as well as the neuropathological consequences. Interleukin-1 is one of the most important cytokines and has several actions in the brain that are critical for the host defense against injury and infection, and it is involved in the initiation of early stages of inflammation. It is believed that interleukin-1 plays a pivotal role in the neuroinflammation associated with certain forms of neurodegeneration, including cerebral ischemia, trauma and excitotoxic brain injury. In this review, we have summarized the experimental data available with regard to the involvement of the interleukin-1 system in kainic acid-induced changes in the brain and emphasized the modulatory role of interleukin-1beta in this model of epilepsy

PubMed Disclaimer

Similar articles

• Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration.
  Eriksson C, Tehranian R, Iverfeldt K, Winblad B, Schultzberg M. Eriksson C, et al. J Neurosci Res. 2000 Apr 15;60(2):266-79. doi: 10.1002/(SICI)1097-4547(20000415)60:2<266::AID-JNR16>3.0.CO;2-P. J Neurosci Res. 2000. PMID: 10740232
• The influence of kainic acid on core temperature and cytokine levels in the brain.
  Oprica M, Spulber SD, Aronsson AF, Post C, Winblad B, Schultzberg M. Oprica M, et al. Cytokine. 2006 Jul;35(1-2):77-87. doi: 10.1016/j.cyto.2006.07.011. Epub 2006 Sep 6. Cytokine. 2006. PMID: 16950633
• [Kainic acid and neurobiology].
  Riljak V, Jandová K, Langmeier M. Riljak V, et al. Cesk Fysiol. 2006;55(3):115-22. Cesk Fysiol. 2006. PMID: 17685017 Review. Czech.
• Kainate receptors in epilepsy and excitotoxicity.
  Vincent P, Mulle C. Vincent P, et al. Neuroscience. 2009 Jan 12;158(1):309-23. doi: 10.1016/j.neuroscience.2008.02.066. Epub 2008 Mar 8. Neuroscience. 2009. PMID: 18400404 Review.

Cited by

• Immunity and Inflammation in Epilepsy.
  Vezzani A, Lang B, Aronica E. Vezzani A, et al. Cold Spring Harb Perspect Med. 2015 Dec 18;6(2):a022699. doi: 10.1101/cshperspect.a022699. Cold Spring Harb Perspect Med. 2015. PMID: 26684336 Free PMC article. Review.
• Honey on brain health: A promising brain booster.
  Zamri NA, Ghani N, Ismail CAN, Zakaria R, Shafin N. Zamri NA, et al. Front Aging Neurosci. 2023 Jan 17;14:1092596. doi: 10.3389/fnagi.2022.1092596. eCollection 2022. Front Aging Neurosci. 2023. PMID: 36733498 Free PMC article. Review.
• Tualang Honey Reduced Neuroinflammation and Caspase-3 Activity in Rat Brain after Kainic Acid-Induced Status Epilepticus.
  Mohd Sairazi NS, Sirajudeen KNS, Muzaimi M, Mummedy S, Asari MA, Sulaiman SA. Mohd Sairazi NS, et al. Evid Based Complement Alternat Med. 2018 Jul 15;2018:7287820. doi: 10.1155/2018/7287820. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30108663 Free PMC article.
• Effects of Troxerutin on Oxidative Stress, Inflammation and Galectin- 3 Expression in Intracerebroventricular Kainic Acid-Induced Neurotoxicity.
  Demir M, Elbe H, Cetinavci D, Saruhan E. Demir M, et al. Inflammation. 2025 Apr 16. doi: 10.1007/s10753-025-02301-9. Online ahead of print. Inflammation. 2025. PMID: 40237932
• Inflammation in epileptogenesis after traumatic brain injury.
  Webster KM, Sun M, Crack P, O'Brien TJ, Shultz SR, Semple BD. Webster KM, et al. J Neuroinflammation. 2017 Jan 13;14(1):10. doi: 10.1186/s12974-016-0786-1. J Neuroinflammation. 2017. PMID: 28086980 Free PMC article. Review.

References

1. 1. Schneider H., Pitossi F., Balschun D., Wagner A., del Rey A., Besedovsky H.O., A neuromodulatory role of interleukin‐1beta in the hippocampus, Proc. Natl. Acad. Sci., 95: 7778–7783, 1998. - PMC - PubMed
2. 1. Opp M.R., Krueger J.M., Interleukin 1‐receptor antagonist blocks interleukin 1‐induced sleep and fever, Am. J. Physiol., 260: R453–457, 1991. - PubMed
3. 1. Berkenbosch F., van Oers J., del Rey A., Tilders F., Besedovsky H., Corticotropin‐releasing factor‐producing neurons in the rat activated by interleukin‐1, Science, 238: 524–526, 1987. - PubMed
4. 1. Tehranian R., Andell‐Jonsson S., Beni S.M., Yatsiv I., Shohami E., Bartfai T., Lundkvist J., Iverfeldt K., Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin‐1 receptor antagonist, J. Neurotrauma, 19: 939–951, 2002. - PubMed
5. 1. Loddick S.A., Wong M.L., Bongiorno P.B., Gold P.W., Licinio J., Rothwell NJ., Endogenous interleukin‐1 receptor antagonist is neuroprotective, Biochem. Biophys. Res. Commun., 234: 211–215, 1997. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Wiley